Meanwhile, previous studies have attested that activation of TrkB/ERK/CREB signaling pathway elicits neuroprotection through neutralizing oxidative stress and repressing neuroinflammatory response in AD (Zhang et al., 2020), which is coincident with our present results. This evidence concerns the gene CREB1 and Alzheimer disease.